Search

Your search keyword '"Tang, Jiake"' showing total 24 results
Start Over Author "Tang, Jiake" Publication Year Range Last 10 years
24 results on '"Tang, Jiake"'

5. Reduced plasma cholesterol in Plasmodium falciparum infection: A meta-analysis

Author

You, Yao, primary, Fan, Hua, additional, Zhang, Shenghui, additional, Hu, Siqi, additional, Tang, Jiake, additional, Chen, Chen, additional, Wen, Wen, additional, Wang, Chunyi, additional, Cheng, Yongran, additional, Zhou, Mengyun, additional, Feng, Zhanhui, additional, Tan, Tao, additional, Qi, Guanming, additional, Zhao, Wenbin, additional, Zhang, Xingwei, additional, Wang, Mingwei, additional, and Dai, Lili, additional

Published
2023
Full Text
View/download PDF

6. Olfactory dysfunction after COVID‐19: metanalysis reveals persistence in one-third of patients 6 months after initial infection

Author

Hu, Siqi, primary, Zhang, Shenghui, additional, You, Yao, additional, Tang, Jiake, additional, Chen, Chen, additional, Wang, Chunyi, additional, Wen, Wen, additional, Wang, Mingwei, additional, Chen, Juan, additional, Luo, Lin, additional, Cheng, Yongran, additional, Zhou, Mengyun, additional, Zhao, Xuezhi, additional, Tan, Tao, additional, Qi, Guanming, additional, and Feng, Zhanhui, additional

Published
2023
Full Text
View/download PDF

7. Multidrug-resistant infection in COVID-19 patients: A meta-analysis

Author

Hu, Siqi, primary, You, Yao, additional, Zhang, Shenghui, additional, Tang, Jiake, additional, Chen, Chen, additional, Wen, Wen, additional, Wang, Chunyi, additional, Cheng, Yongran, additional, Zhou, Mengyun, additional, Feng, Zhanhui, additional, Tan, Tao, additional, Qi, Guanming, additional, Wang, Mingwei, additional, and Liu, Xiaoyan, additional

Published
2023
Full Text
View/download PDF

10. A meta-analysis of the association between calprotectin and the severity of COVID-19

Author

Mao, Qin, Wang, Chunyi, Wen, Wen, Zhou, Mengyun, Tang, Jiake, Chen, Chen, Cheng, Yongran, Wu, Qi, Zhang, Xingwei, Feng, Zhanhui, and Wang, Mingwei

Subjects
Adult, Microbiology (medical), Infectious Diseases, SARS-CoV-2, COVID-19, Humans, Letter to the Editor, Leukocyte L1 Antigen Complex, Severity of Illness Index, Biomarkers
Published
2022

12. Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology

Author

Peng, Dandan, primary, Yu, Zhenqiu, additional, Wang, Mingwei, additional, Shi, Junping, additional, Sun, Lei, additional, Zhang, Yuanyuan, additional, Zhao, Wenbin, additional, Chen, Chen, additional, Tang, Jiake, additional, Wang, Chunyi, additional, Ni, Jie, additional, Wen, Wen, additional, and Jiang, Jingjie, additional

Published
2022
Full Text
View/download PDF

18. Air Quality During The COVID-19 Epidemic in China

Author

Lv, Shijin, primary, Wen, Wen, additional, Wang, Chunyi, additional, Chen, Chen, additional, Tang, Jiake, additional, Cheng, Yongran, additional, Zhou, Mengyun, additional, Wu, Qi, additional, Zhang, Xingwei, additional, Wang, Ming-wei, additional, Feng, Zhanhui, additional, and Yang, Dong, additional

Published
2022
Full Text
View/download PDF

22. Investigating the impact of empagliflozin on the retina of diabetic mice

Author

Chen, Juan, Zhang, Shenghui, You, Yao, Hu, Siqi, Tang, Jiake, Chen, Chen, Wen, Wen, Tang, Ting, Yu, Qingwen, Tong, Xuhan, Wang, Chunyi, Zhao, Wenbin, Fu, Xinyan, Zhang, Xingwei, Wang, Mingwei, and Gong, Wenyan

Abstract

Background Diabetic retinopathy (DR) frequently results in compromised visual function, with hyperglycemia-induced disruption of the blood-retinal barrier (BRB) through various pathways as a critical mechanism. Existing DR treatments fail to address early and potentially reversible microvascular alterations. This study examined the effects of empagliflozin (EMPA), a selective Sodium-glucose transporter 2 (SGLT2) inhibitor, on the retina of db/db mice. The objective of this study is to investigate the potential role of EMPA in the prevention and delay of DR.Methods db/dbmice were randomly assigned to either the EMPA treatment group (db/db?+?Emp) or the model group (db/db), while C57 mice served as the normal control group (C57). Mice in the db/db?+?Emp group received EMPA for eight weeks. Body weight, fasting blood glucose (FBG), and blood VEGF were subsequently measured in all mice, along with the detection of specific inflammatory factors and BRB proteins in the retina. Retinal SGLT2 protein expression was compared using immunohistochemical analysis, and BRB structural changes were observed via electron microscopy.Results EMPA reduced FBG, blood VEGF, and retinal inflammatory factors TNF-a, IL-6, and VEGF levels in the eye tissues of db/dbmice. EMPA also increased Claudin-1, Occludin-1, and ZO-1 levels while decreasing ICAM-1 and Fibronectin, thereby preserving BRB function in db/dbmice. Immunohistochemistry revealed that EMPA reduced SGLT2 expression in the retina of diabetic mice, and electron microscopy demonstrated that EMPA diminished tight junction damage between retinal vascular endothelial cells and prevented retinal vascular basement membrane thickening in diabetic mice.Conclusion EMPA mitigates inflammation and preserves BRB structure and function, suggesting that it may prevent DR or serve as an effective early treatment for DR.

Published
2024
Full Text
View/download PDF

24. Association Between Remnant Cholesterol and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis.

Author

Tang J, Tang T, Yu Q, Tong X, Liu C, Chen C, Hu S, Zhang S, You Y, Wang C, Li J, Wen W, Chen J, Zhang X, Wang M, and Tong F

Abstract

Lipid disorders are related to the risk of nonalcoholic fatty liver disease (NAFLD). Remnant cholesterol (RC), a nonclassical and once-neglected risk factor for NAFLD, has recently received new attention. In this study, we assessed the relationship between the RC levels and NAFLD risk. We searched across PubMed, Web of Science, Embase, Cochrane Library, and China National Knowledge Infrastructure, with no restrictions on publication languages. Retrospective cohort studies and cross-sectional studies were enrolled from the inception of the databases until August 6, 2023. A random-effect model was applied to construct the mean difference, and a 95% confidence interval was applied to assess the relationship between the RC levels and NAFLD risk. We used two methods to estimate RC levels: Calculated-1 subtracts low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol from total cholesterol; Calculated-2 uses the Friedewald formula for LDL-C when triglycerides are <4.0 mmol/L, otherwise directly measured. A total of 265 published studies were selected through preliminary retrieval. Of these, six studies met the inclusion requirements and were enrolled in the meta-analysis. The RC level in the NAFLD group was significantly higher than that in the non-NAFLD group (mean difference: 0.18, 95% confidence interval: 0.10-0.26, P < 0.00001). We conducted subgroup analyses of computational methods and geographic regions. Notably, in the subgroup analysis of Calculation Method 2, the NAFLD group had significantly higher RC levels than the non-NAFLD group. On the other hand, in Calculation Method 1, the difference between the two groups was insignificant. In both the Asian and non-Asian populations, the RC levels were significantly higher in the NAFLD group than in the non-NAFLD group. The association of RC with an increased NAFLD risk was not dependent on the triglyceride. This meta-analysis suggests that elevated RC levels are associated with an increased risk of NAFLD. In addition to the conventional risk factors for fatty liver, clinicians should be concerned about the RC levels in the clinic.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results